1. Treating HFrEF: Challenges Faced

2. Recommendation for Implantable Cardioverter Defibrillator in Patients With HF

3. Terminology in Heart Failure: What Does It Mean?

4. ESC Guidelines: Treatment of Symptomatic HFrEF

5. Extensive Therapies for Patients With HFrEF in Select Patients

6. ESC Guidelines: Recommendations for ARNI Use

7. Prescribing Information for Sacubitril/Valsartan: European Label

8. PARADIGM-HF: Primary and Secondary Outcomes

9. PARADIGM-HF: Adverse Events

10. ESC Guidelines: Recommendations for ARNI Use

11. Examining Why Recommended Therapies Are Not Provided: Implementation Science

12. Barriers to Uptitration of HF Therapies

13. ARNI Use in Patients With HFrEF

14. Titration of Medications in HFrEF: Implementing Evidence-Based HFrEF Therapy

15. Managing Hypokalemia/Hyperkalemia in HF

16. Hyperkalemia: Observations From BIOSTAT-CHF

17. Technology and Transplantation in HF Management

18. Potential New Drugs in the Pipeline for HF Management

19. Historical Development of Drug Therapy in HFrEF

20. Abbreviations

21. Abbreviations (cont)